rs8074524
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_139276.3(STAT3):c.2102-356G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.233 in 373,194 control chromosomes in the GnomAD database, including 11,276 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 5193 hom., cov: 32)
Exomes 𝑓: 0.22 ( 6083 hom. )
Consequence
STAT3
NM_139276.3 intron
NM_139276.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.212
Publications
28 publications found
Genes affected
STAT3 (HGNC:11364): (signal transducer and activator of transcription 3) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. This gene also plays a role in regulating host response to viral and bacterial infections. Mutations in this gene are associated with infantile-onset multisystem autoimmune disease and hyper-immunoglobulin E syndrome. [provided by RefSeq, Aug 2020]
STAT3 Gene-Disease associations (from GenCC):
- hyper-IgE recurrent infection syndrome 1, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
- STAT3-related early-onset multisystem autoimmune diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, ClinGen
- permanent neonatal diabetes mellitusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STAT3 | NM_139276.3 | c.2102-356G>A | intron_variant | Intron 21 of 23 | ENST00000264657.10 | NP_644805.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STAT3 | ENST00000264657.10 | c.2102-356G>A | intron_variant | Intron 21 of 23 | 1 | NM_139276.3 | ENSP00000264657.4 |
Frequencies
GnomAD3 genomes AF: 0.245 AC: 37252AN: 151904Hom.: 5183 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
37252
AN:
151904
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.224 AC: 49559AN: 221172Hom.: 6083 Cov.: 0 AF XY: 0.232 AC XY: 27127AN XY: 117110 show subpopulations
GnomAD4 exome
AF:
AC:
49559
AN:
221172
Hom.:
Cov.:
0
AF XY:
AC XY:
27127
AN XY:
117110
show subpopulations
African (AFR)
AF:
AC:
2614
AN:
7090
American (AMR)
AF:
AC:
1458
AN:
10610
Ashkenazi Jewish (ASJ)
AF:
AC:
1860
AN:
6478
East Asian (EAS)
AF:
AC:
4696
AN:
13134
South Asian (SAS)
AF:
AC:
9730
AN:
32608
European-Finnish (FIN)
AF:
AC:
1916
AN:
9590
Middle Eastern (MID)
AF:
AC:
226
AN:
890
European-Non Finnish (NFE)
AF:
AC:
24246
AN:
128552
Other (OTH)
AF:
AC:
2813
AN:
12220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
1827
3653
5480
7306
9133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.245 AC: 37295AN: 152022Hom.: 5193 Cov.: 32 AF XY: 0.246 AC XY: 18292AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
37295
AN:
152022
Hom.:
Cov.:
32
AF XY:
AC XY:
18292
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
15017
AN:
41410
American (AMR)
AF:
AC:
2286
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1036
AN:
3466
East Asian (EAS)
AF:
AC:
1863
AN:
5172
South Asian (SAS)
AF:
AC:
1469
AN:
4818
European-Finnish (FIN)
AF:
AC:
2069
AN:
10578
Middle Eastern (MID)
AF:
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12753
AN:
67984
Other (OTH)
AF:
AC:
539
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1394
2788
4181
5575
6969
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1347
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.